Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2018

May 3, 2018

29745_dirs_2018-05-03_25c6870c-3729-48a1-a859-fca816b248c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-05-01

Reporting Person: Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-01 Common Stock M 20000 Acquired 158468 Direct
2018-05-01 Common Stock F 8934 $81.07 Disposed 149534 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-01 Restricted Stock Unit $ M 20000 Disposed 2018-05-01 Common Stock (20000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5084 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.